Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Malaria in Malawi
NCT02637128Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Mar 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artemether + lumefantrine, artesunate + amodiaquine in Plasmodium falciparum malaria, sponsored by Centers for Disease Control and Prevention. Started Mar 2014; status: completed.
02
Drugs
artemether + lumefantrineartesunate + amodiaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02637128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02637128.